Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 6Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Melanoma 4Neoplasms 2Leukemia, Myeloid, Acute 2Breast Neoplasms 2Sepsis 1Sarcoma 1Rhabdomyosarcoma 1Prostatic Neoplasms 1Pathologic Complete Response 1Neutropenia 1Neuroblastoma 1Neoplasm Metastasis 1Multiple Myeloma 1Malignant mesenchymal tumor 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hematologic Diseases 1Graft vs Host Disease 1Gliosarcoma 1Glioblastoma 1Fever 1Carcinoma, Renal Cell 1Brain Neoplasms 1

Interventions

Dexamethasone 169Bortezomib 92Lenalidomide 85daratumumab 44Thalidomide 44pomalidomide 43Melphalan 40Cyclophosphamide 33carfilzomib 29Calcium Dobesilate 27Prednisone 19Doxorubicin 16elotuzumab 14isatuximab 12Filgrastim 12ixazomib 11Vincristine 10Peripheral Blood Stem Cell Transplantation 10belantamab mafodotin 9Granulocyte Colony-Stimulating Factor 9Zoledronic Acid 8selinexor 7dexamethasone acetate 7Epoetin Alfa 7Etoposide 6fludarabine 5Cisplatin 5Carmustine 5iberdomide 4Radiotherapy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Multiple Myeloma × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT00001561 2007-09-24

Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
30 enrolled
Plasma cell

Graft vs Host Disease, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡